← Back to Search

Behavioral Intervention

Free2b for Substance Abuse

N/A
Waitlist Available
Led By Traci M. Schwinn, PhD
Research Sponsored by Columbia University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3-year follow-up
Awards & highlights

Study Summary

This trial will test a web-based drug abuse prevention program with a sample of 15- to 17-year-old sexual minority youth.

Who is the study for?
This trial is for teenagers aged 15-17 in the U.S. who identify as gay, lesbian, bisexual, or unsure of their sexual orientation and can speak and read English. They must have private access to a desktop, laptop, or tablet with internet.Check my eligibility
What is being tested?
The study is testing 'Free2b', a web-based drug abuse prevention program tailored for young sexual minority individuals against an attention-placebo control to see its effectiveness over time.See study design
What are the potential side effects?
Since this intervention involves educational content rather than medication, traditional side effects are not expected; however, participants may experience emotional discomfort discussing sensitive topics.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3-year follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3-year follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of times youth binge drank in the past month
Number of times youth drank alcohol in the past month
Number of times youth smoked cigarettes in the past month
+3 more
Secondary outcome measures
Mean scores for Assertiveness
Mean scores for Consequences of Substance Use
Mean scores for Coping
+7 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: InterventionExperimental Treatment1 Intervention
9 sessions and website with entertainment features and resources
Group II: ControlPlacebo Group1 Intervention
website with entertainment features and resources

Find a Location

Who is running the clinical trial?

Columbia UniversityLead Sponsor
1,432 Previous Clinical Trials
2,459,757 Total Patients Enrolled
8 Trials studying Substance Abuse
7,220 Patients Enrolled for Substance Abuse
National Institute on Drug Abuse (NIDA)NIH
2,467 Previous Clinical Trials
2,617,907 Total Patients Enrolled
152 Trials studying Substance Abuse
705,926 Patients Enrolled for Substance Abuse
Traci M. Schwinn, PhDPrincipal InvestigatorColumbia University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are additional participants being enrolled in this investigation?

"According to the data on clinicaltrials.gov, this specific medical trial has stopped seeking out patients, having last updated its information in October of 2022. Fortunately, there are still 362 other trials actively enrolling participants at present."

Answered by AI

To whom does this research offer an opportunity to participate?

"For this clinical trial, 1216 adolescents aged 15-17 who have substance abuse disorder must be enrolled. Potential participants should also meet the following criteria: self-identify as lesbian, gay, bisexual or questioning; possess access to a personal computing device with broadband internet connection; and primarily reside outside of the United States of America."

Answered by AI

Does the study consider applicants beyond their thirties?

"According to the inclusion criteria, potential participants must be between fifteen and seventeen years old. There are 76 studies involving minors while 255 focus on those above retirement age."

Answered by AI

What aims is this inquiry seeking to accomplish?

"The primary goal of this 3-year clinical trial is to assess the frequency at which youth vape. Additionally, researchers will also measure self-esteem, coping skills and assertiveness by calculating mean scores on respective scales. Self-esteem index ranges from 1 (higher) to 4 (lower); a lower score exhibits better results, whereas for Coping and Assertiveness it's 0 (high) to 3 (poor), with smaller numbers indicating greater efficacy in managing difficult life circumstances or asserting one's self respectively."

Answered by AI
~232 spots leftby Apr 2025